Ultrasonic Preparation of Nano-CaCO Templates and Hollow Mesoporous SiO Nanoparticles for Voriconazole Loading.

AAPS PharmSciTech

Department of Drug Science and Technology and NIS - Centre, University of Turin, Via Pietro Giuria 9, Turin, 10125, Italy.

Published: July 2024

AI Article Synopsis

  • Researchers created calcium carbonate (CaCO) nanoparticles as templates and used them to produce hollow mesoporous silica nanoparticles (HMSNs) for drug delivery.
  • The HMSNs, with a high surface area and specific pore structure, effectively encapsulated the antifungal drug voriconazole (VOR), with a loading capacity of nearly 8%.
  • The study found that VOR release from the HMSNs followed Fickian diffusion, with higher cumulative release at elevated temperatures and lower pH levels.

Article Abstract

CaCO nanoparticles (nano-CaCO) as nano-templates were prepared using CaCl and NaCO solutions under controlled sonication (19.5 kHz). Using the same ultrasonic device, subsequently, hollow mesoporous silica nanoparticles (HMSNs) were obtained by the hard template of nano-CaCO. HMSNs were selected as carriers for the antifungal drug voriconazole (VOR) loading to overcome poor water solubility. Three-dimensional CaCO nanosheets HMSNs were obtained under gentle sonication. Three-dimensional CaCO nanosheets of 24.5 nm (hydrodynamic diameter) were obtained under 17.6 W for 3 min. HMSNs were synthesized by double-template method with nano-CaCO as the hard template. Transmission electron microscopy measurements showed that the prepared HMSNs possess hollow structures with particle size between 110 and 120 nm. Nitrogen physisorption at -196 °C revealed that the HMSNs had high surface area (401.57 m/g), high pore volume (0.11 cm/g), and uniform pore size (2.22 nm) that facilitated the effective encapsulation of VOR in the HMSNs. The loading capacity of VOR (wt%) on the HMSNs was 7.96%, and the total VOR release amount of VOR-HMSNs material was 71.40% at 480 min. The kinetic model confirmed that the release mechanism of HMSNs nanoparticles followed Fickian diffusion at pH = 7.4 and 37 °C. Moreover, the cumulative VOR release at 42 °C (86.05%) was higher than that at 37 °C (71.40%). The cumulative release amount of VOR from the VOR-HMSNs material was 92.37% at pH = 5.8 at the same temperature. Both nano-CaCO templates and HMSNs were prepared by sonication at 19.5 kHz. The as-prepared HMSNs can effectively encapsulate VOR and released drug by Fickian diffusion.

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12249-024-02872-0DOI Listing

Publication Analysis

Top Keywords

hmsns
11
nano-caco templates
8
hollow mesoporous
8
sonication 195 khz
8
hard template
8
three-dimensional caco
8
caco nanosheets
8
vor release
8
release amount
8
vor-hmsns material
8

Similar Publications

Hollow mesoporous silica nanoparticles for drug formulation and delivery: Opportunities for cancer therapy.

Colloids Surf B Biointerfaces

January 2025

Shaanxi Key Laboratory of Catalysis, School of Chemistry and Environment Science, Shaanxi University of Technology, No.1 East 1st Ring Road, Hanzhong, Shaanxi 723001, PR China.

The advantages of large surface area, high volume ratio, good biocompatibility, and controllable surface functionalization make hollow mesoporous silica nanoparticles (HMSNs) an ideal drug carrier. HMSNs can achieve high efficiency, targeting, and controlled release by adjusting the microstructure and surface modification of its particles, which makes it broad application prospects in the field of medical therapy, especially in cancer therapy. Numerous studies have shown that preparation method, shape, particle size, hollow inner diameter, aperture and wall thickness of the HMSNs, the characteristics of the drugs, the interaction between the drugs and the carriers, and the external environment all closely affect the drug delivery, release, and efficacy.

View Article and Find Full Text PDF

Research on stimuli-responsive micro-nanocontainers has gained attention for targeted corrosion inhibition and controlled emulsification-demulsification in oil recovery. However, existing nanocontainers face issues like irreversible drug release and limited functionality. This study presents a multi-functional nanocontainer design with reversible drug release and emulsification-demulsification capabilities.

View Article and Find Full Text PDF

Nanotechnology-Driven Delivery of Caffeine Using Ultradeformable Liposomes-Coated Hollow Mesoporous Silica Nanoparticles for Enhanced Follicular Delivery and Treatment of Androgenetic Alopecia.

Int J Mol Sci

November 2024

Thammasat University Research Unit in Smart Materials and Innovative Technology for Pharmaceutical Applications (SMIT-Pharm), Faculty of Pharmacy, Thammasat University, Pathumthani 12120, Thailand.

Article Synopsis
  • Androgenetic alopecia (AGA) is a hair loss condition linked to the hormone dihydrotestosterone (DHT), and the study focuses on enhancing caffeine delivery to hair follicles to counteract its effects.
  • Researchers developed a new drug delivery system using caffeine-loaded hollow mesoporous silica nanoparticles coated with ultradeformable liposomes (ULp-Caf@HMSNs), which improve caffeine's ability to penetrate skin and reduce hair loss.
  • Results showed that this new system is non-toxic to hair follicle cells, increases cell viability, and effectively reduces harmful oxidative stress in cells affected by DHT, making it a promising alternative to existing treatments like minoxidil.
View Article and Find Full Text PDF
Article Synopsis
  • Pancreatic cancer (PC) is impacted by fibrotic mesenchyme, which hinders immunotherapy effectiveness; low-dose arsenic trioxide (ATO) can inhibit activation of pancreatic stellate cells (PSCs) to improve treatment response.* -
  • The study utilized various models to show that low-dose ATO remodels the extracellular matrix (ECM), leading to increased CD8T cell infiltration and enhanced effects of anti-PD-L1 therapy.* -
  • ATO's ability to regulate LOXL3 in PSCs suggests it can effectively remodel ECM and sensitize immunotherapy, positioning it as a promising strategy for treating pancreatic cancer.*
View Article and Find Full Text PDF

The clinical treatment of epilepsy is faced with challenges. On the one hand, the effectiveness of existing antiepileptic drugs (AEDs) is limited by the blood‒brain barrier (BBB); on the other hand, changes in the inflammatory microenvironment during epileptogenesis are often neglected. The death-associated protein kinase 1 inhibitor TC-DAPK6 and the fluorescent probe rhodamine B were encapsulated in hollow mesoporous silica nanocarriers (HMSNs), which were then coated with a macrophage membrane to prepare macrophage membrane-biomimetic nanoparticles, namely, MA@RT-HMSNs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!